Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Nov;76(901):690–693. doi: 10.1136/pmj.76.901.690

Unknown primary tumours

H Hillen 1
PMCID: PMC1741801  PMID: 11060142

Abstract

Unknown primary tumours (UPTs) are defined by the absence of a primary tumour in biopsy proved metastatic cancer. These tumours have a specific biology with clinical characteristics of rapid progression and random atypical metastases. Cytogenetic abnormalities have been demonstrated, particularly deletion of chromosome 1p. Diagnostic evaluation that includes pathology review, physical examination, chest radiography, computed tomography of the abdomen, and mammography is directed at the identification of treatable subsets. Based on clinicopathological criteria, therapy responsive subsets of patients with UPTs can be defined. These subsets have a better prognosis than the average median survival time of four months in patients with UPTs.


Keywords: unknown primary tumours; metastases

Full Text

The Full Text of this article is available as a PDF (119.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbruzzese J. L., Abbruzzese M. C., Hess K. R., Raber M. N., Lenzi R., Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol. 1994 Jun;12(6):1272–1280. doi: 10.1200/JCO.1994.12.6.1272. [DOI] [PubMed] [Google Scholar]
  2. Abbruzzese J. L., Abbruzzese M. C., Lenzi R., Hess K. R., Raber M. N. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol. 1995 Aug;13(8):2094–2103. doi: 10.1200/JCO.1995.13.8.2094. [DOI] [PubMed] [Google Scholar]
  3. Abbruzzese J. L., Lenzi R., Raber M. N., Pathak S., Frost P. The biology of unknown primary tumors. Semin Oncol. 1993 Jun;20(3):238–243. [PubMed] [Google Scholar]
  4. Altman E., Cadman E. An analysis of 1539 patients with cancer of unknown primary site. Cancer. 1986 Jan 1;57(1):120–124. doi: 10.1002/1097-0142(19860101)57:1<120::aid-cncr2820570124>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. Bell C. W., Pathak S., Frost P. Unknown primary tumors: establishment of cell lines, identification of chromosomal abnormalities, and implications for a second type of tumor progression. Cancer Res. 1989 Aug 1;49(15):4311–4315. [PubMed] [Google Scholar]
  6. Dalrymple J. C., Bannatyne P., Russell P., Solomon H. J., Tattersall M. H., Atkinson K., Carter J., Duval P., Elliott P., Friedlander M. Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer. 1989 Jul 1;64(1):110–115. doi: 10.1002/1097-0142(19890701)64:1<110::aid-cncr2820640120>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  7. Daugaard G. Unknown primary tumours. Cancer Treat Rev. 1994 Apr;20(2):119–147. doi: 10.1016/0305-7372(94)90024-8. [DOI] [PubMed] [Google Scholar]
  8. Ellerbroek N., Holmes F., Singletary E., Evans H., Oswald M., McNeese M. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer. 1990 Oct 1;66(7):1461–1467. doi: 10.1002/1097-0142(19901001)66:7<1461::aid-cncr2820660704>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  9. Guarischi A., Keane T. J., Elhakim T. Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases. Cancer. 1987 Feb 1;59(3):572–577. doi: 10.1002/1097-0142(19870201)59:3<572::aid-cncr2820590336>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  10. Hainsworth J. D., Erland J. B., Kalman L. A., Schreeder M. T., Greco F. A. Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide. J Clin Oncol. 1997 Jun;15(6):2385–2393. doi: 10.1200/JCO.1997.15.6.2385. [DOI] [PubMed] [Google Scholar]
  11. Hainsworth J. D., Greco F. A. Treatment of patients with cancer of an unknown primary site. N Engl J Med. 1993 Jul 22;329(4):257–263. doi: 10.1056/NEJM199307223290407. [DOI] [PubMed] [Google Scholar]
  12. Hammar S. P. Metastatic adenocarcinoma of unknown primary origin. Hum Pathol. 1998 Dec;29(12):1393–1402. doi: 10.1016/s0046-8177(98)90007-7. [DOI] [PubMed] [Google Scholar]
  13. Kirsten F., Chi C. H., Leary J. A., Ng A. B., Hedley D. W., Tattersall M. H. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets. Q J Med. 1987 Feb;62(238):143–161. [PubMed] [Google Scholar]
  14. Le Chevalier T., Cvitkovic E., Caille P., Harvey J., Contesso G., Spielmann M., Rouesse J. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med. 1988 Sep;148(9):2035–2039. [PubMed] [Google Scholar]
  15. Leonard R. J., Nystrom J. S. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site. Semin Oncol. 1993 Jun;20(3):244–250. [PubMed] [Google Scholar]
  16. Mackay B., Ordonez N. G. Pathological evaluation of neoplasms with unknown primary tumor site. Semin Oncol. 1993 Jun;20(3):206–228. [PubMed] [Google Scholar]
  17. Merson M., Andreola S., Galimberti V., Bufalino R., Marchini S., Veronesi U. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer. 1992 Jul 15;70(2):504–508. doi: 10.1002/1097-0142(19920715)70:2<504::aid-cncr2820700221>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  18. Nystrom J. S., Weiner J. M., Heffelfinger-Juttner J., Irwin L. E., Bateman J. R., Wolf R. M. Metastatic and histologic presentations in unknown primary cancer. Semin Oncol. 1977 Mar;4(1):53–58. [PubMed] [Google Scholar]
  19. Nystrom J. S., Weiner J. M., Wolf R. M., Bateman J. R., Viola M. V. Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA. 1979 Jan 26;241(4):381–383. [PubMed] [Google Scholar]
  20. Ruddon R. W., Norton S. E. Use of biological markers in the diagnosis of cancers of unknown primary tumor. Semin Oncol. 1993 Jun;20(3):251–260. [PubMed] [Google Scholar]
  21. Sporn J. R., Greenberg B. R. Empiric chemotherapy in patients with carcinoma of unknown primary site. Am J Med. 1990 Jan;88(1):49–55. doi: 10.1016/0002-9343(90)90127-y. [DOI] [PubMed] [Google Scholar]
  22. Stewart J. F., Tattersall M. H., Woods R. L., Fox R. M. Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. Br Med J. 1979 Jun 9;1(6177):1530–1533. doi: 10.1136/bmj.1.6177.1530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tell D. T., Khoury J. M., Taylor H. G., Veasey S. P. Atypical metastasis from prostate cancer. Clinical utility of the immunoperoxidase technique for prostate-specific antigen. JAMA. 1985 Jun 28;253(24):3574–3575. doi: 10.1001/jama.253.24.3574. [DOI] [PubMed] [Google Scholar]
  24. Walsh J. W., Rosenfield A. T., Jaffe C. C., Schwartz P. E., Simeone J., Dembner A. G., Taylor K. J. Prospective comparison of ultrasound and computed tomography in the evaluation of gynecologic pelvic masses. AJR Am J Roentgenol. 1978 Dec;131(6):955–960. doi: 10.2214/ajr.131.6.955. [DOI] [PubMed] [Google Scholar]
  25. de Braud F., Heilbrun L. K., Ahmed K., Sakr W., Ensley J. F., Kish J. A., Tapazoglou E., al-Sarraf M. Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment. Cancer. 1989 Jul 15;64(2):510–515. doi: 10.1002/1097-0142(19890715)64:2<510::aid-cncr2820640225>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES